These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 38672622)

  • 61. Exosomal miRNA-106b from cancer-associated fibroblast promotes gemcitabine resistance in pancreatic cancer.
    Fang Y; Zhou W; Rong Y; Kuang T; Xu X; Wu W; Wang D; Lou W
    Exp Cell Res; 2019 Oct; 383(1):111543. PubMed ID: 31374207
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Enhancement of cytotoxic effects of gemcitabine by Dclk1 inhibition through suppression of Chk1 phosphorylation in human pancreatic cancer cells.
    Kawamura D; Takemoto Y; Nishimoto A; Ueno K; Hosoyama T; Shirasawa B; Tanaka T; Kugimiya N; Harada E; Hamano K
    Oncol Rep; 2017 Nov; 38(5):3238-3244. PubMed ID: 29048622
    [TBL] [Abstract][Full Text] [Related]  

  • 63. M1 Macrophage-Derived Exosomes Loaded with Gemcitabine and Deferasirox against Chemoresistant Pancreatic Cancer.
    Zhao Y; Zheng Y; Zhu Y; Zhang Y; Zhu H; Liu T
    Pharmaceutics; 2021 Sep; 13(9):. PubMed ID: 34575569
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Gemcitabine Resistance in Pancreatic Ductal Carcinoma Cell Lines Stems from Reprogramming of Energy Metabolism.
    Fujiwara-Tani R; Sasaki T; Takagi T; Mori S; Kishi S; Nishiguchi Y; Ohmori H; Fujii K; Kuniyasu H
    Int J Mol Sci; 2022 Jul; 23(14):. PubMed ID: 35887170
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Luteolin exhibits synergistic therapeutic efficacy with erastin to induce ferroptosis in colon cancer cells through the HIC1-mediated inhibition of GPX4 expression.
    Zheng Y; Li L; Chen H; Zheng Y; Tan X; Zhang G; Jiang R; Yu H; Lin S; Wei Y; Wang Y; Zhang R; Liu Z; Wu J
    Free Radic Biol Med; 2023 Nov; 208():530-544. PubMed ID: 37717793
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Co-Delivery of Gemcitabine and Mcl-1 SiRNA via Cationic Liposome-Based System Enhances the Efficacy of Chemotherapy in Pancreatic Cancer.
    Wang Y; Gao F; Jiang X; Zhao X; Wang Y; Kuai Q; Nie G; He M; Pan Y; Shi W; Ren S; Yu Q
    J Biomed Nanotechnol; 2019 May; 15(5):966-978. PubMed ID: 30890228
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Natural compound Oblongifolin C confers gemcitabine resistance in pancreatic cancer by downregulating Src/MAPK/ERK pathways.
    Li Y; Xi Z; Chen X; Cai S; Liang C; Wang Z; Li Y; Tan H; Lao Y; Xu H
    Cell Death Dis; 2018 May; 9(5):538. PubMed ID: 29749405
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Bitter melon juice intake with gemcitabine intervention circumvents resistance to gemcitabine in pancreatic patient-derived xenograft tumors.
    Dhar D; Raina K; Kumar D; Wempe MF; Bagby SM; Pitts TM; Orlicky DJ; Agarwal C; Messersmith WA; Agarwal R
    Mol Carcinog; 2020 Oct; 59(10):1227-1240. PubMed ID: 32816368
    [TBL] [Abstract][Full Text] [Related]  

  • 69. RRP9 promotes gemcitabine resistance in pancreatic cancer via activating AKT signaling pathway.
    Zhang Z; Yu H; Yao W; Zhu N; Miao R; Liu Z; Song X; Xue C; Cai C; Cheng M; Lin K; Qi D
    Cell Commun Signal; 2022 Nov; 20(1):188. PubMed ID: 36434608
    [TBL] [Abstract][Full Text] [Related]  

  • 70. A randomized phase II study of full dose gemcitabine versus reduced dose gemcitabine and nab-paclitaxel in vulnerable patients with non-resectable pancreatic cancer (DPCG-01).
    Rasmussen LS; Winther SB; Chen IM; Weber B; Ventzel L; Liposits G; Johansen JS; Detlefsen S; Egendal I; Shim S; Christensen S; Pfeiffer P; Ladekarl M
    BMC Cancer; 2023 Jun; 23(1):552. PubMed ID: 37328835
    [TBL] [Abstract][Full Text] [Related]  

  • 71. The histone methyltransferase G9a as a therapeutic target to override gemcitabine resistance in pancreatic cancer.
    Pan MR; Hsu MC; Luo CW; Chen LT; Shan YS; Hung WC
    Oncotarget; 2016 Sep; 7(38):61136-61151. PubMed ID: 27531902
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Bub1 and aurora B cooperate to maintain BubR1-mediated inhibition of APC/CCdc20.
    Morrow CJ; Tighe A; Johnson VL; Scott MI; Ditchfield C; Taylor SS
    J Cell Sci; 2005 Aug; 118(Pt 16):3639-52. PubMed ID: 16046481
    [TBL] [Abstract][Full Text] [Related]  

  • 73. The effects of novel chitosan-targeted gemcitabine nanomedicine mediating cisplatin on epithelial mesenchymal transition, invasion and metastasis of pancreatic cancer cells.
    Yu H; Song H; Xiao J; Chen H; Jin X; Lin X; Pan B; Ji W
    Biomed Pharmacother; 2017 Dec; 96():650-658. PubMed ID: 29035831
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Exosomes confer chemoresistance to pancreatic cancer cells by promoting ROS detoxification and miR-155-mediated suppression of key gemcitabine-metabolising enzyme, DCK.
    Patel GK; Khan MA; Bhardwaj A; Srivastava SK; Zubair H; Patton MC; Singh S; Khushman M; Singh AP
    Br J Cancer; 2017 Feb; 116(5):609-619. PubMed ID: 28152544
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Upstream stimulatory factor 2 inhibits erastin-induced ferroptosis in pancreatic cancer through transcriptional regulation of pyruvate kinase M2.
    Chen M; Li X; Du B; Chen S; Li Y
    Biochem Pharmacol; 2022 Nov; 205():115255. PubMed ID: 36210578
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Downregulation of STAT3/NF-κB potentiates gemcitabine activity in pancreatic cancer cells.
    Gong J; Muñoz AR; Pingali S; Payton-Stewart F; Chan DE; Freeman JW; Ghosh R; Kumar AP
    Mol Carcinog; 2017 Feb; 56(2):402-411. PubMed ID: 27208550
    [TBL] [Abstract][Full Text] [Related]  

  • 77. The inhibition of heme oxygenase-1 enhances the chemosensitivity and suppresses the proliferation of pancreatic cancer cells through the SHH signaling pathway.
    Han L; Jiang J; Ma Q; Wu Z; Wang Z
    Int J Oncol; 2018 Jun; 52(6):2101-2109. PubMed ID: 29620188
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Identifying microRNA-mRNA regulatory network in gemcitabine-resistant cells derived from human pancreatic cancer cells.
    Shen Y; Pan Y; Xu L; Chen L; Liu L; Chen H; Chen Z; Meng Z
    Tumour Biol; 2015 Jun; 36(6):4525-34. PubMed ID: 25722110
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Predicting the chemosensitivity of pancreatic cancer cells by quantifying the expression levels of genes associated with the metabolism of gemcitabine and 5-fluorouracil.
    Kurata N; Fujita H; Ohuchida K; Mizumoto K; Mahawithitwong P; Sakai H; Onimaru M; Manabe T; Ohtsuka T; Tanaka M
    Int J Oncol; 2011 Aug; 39(2):473-82. PubMed ID: 21617862
    [TBL] [Abstract][Full Text] [Related]  

  • 80. The MST4-MOB4 complex disrupts the MST1-MOB1 complex in the Hippo-YAP pathway and plays a pro-oncogenic role in pancreatic cancer.
    Chen M; Zhang H; Shi Z; Li Y; Zhang X; Gao Z; Zhou L; Ma J; Xu Q; Guan J; Cheng Y; Jiao S; Zhou Z
    J Biol Chem; 2018 Sep; 293(37):14455-14469. PubMed ID: 30072378
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.